dermovate 0.5 mg/1 g mast
evropa lijek pharma d.o.o. - klobetazol - mast - 0.5 mg/1 g - 1 g masti sadrži 0,5 mg klobetazol propionata
dermovate 0.5 mg/1 g krema
evropa lijek pharma d.o.o. - klobetazol - krema - 0.5 mg/1 g - 1 g kreme sadrži 0,5 mg klobetazol propionata
cutticom 1 mg/g krema
sandoz d.o.o., maksimirska 120, zagreb - mometasonum - krema - 0,1% - urbroj: jedan gram kreme sadrži 1 mg mometazonfuroata (0,1% w/w mometazonfuroata)
trimbow
chiesi farmaceutici s.p.a. - beclometasone дипропионат, формотерола фумарата dihidrat bromid glycopyrronium - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
trydonis
chiesi farmaceutici s.p.a. - beclometasone дипропионат, формотерола фумарата dihidrat, glycopyrronium - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - terapija održavanja u odraslih bolesnika s umjerenim do teške kronične opstruktivne plućne bolesti (kopb) koji se adekvatno liječe kombinacijom inhalacijski kortikosteroid i dugodjelujući beta2-agonist (za učinak na simptome kontrole i prevenciji egzacerbacije vidjeti dio 5.
riarify (previously chf 5993 chiesi farmaceutici s.p.a.)
chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - terapija održavanja u odraslih bolesnika s umjerenim do teške kronične opstruktivne plućne bolesti (kopb) koji se adekvatno liječe kombinacijom inhalacijski kortikosteroid i dugodjelujući beta2-agonist (za učinak na simptome kontrole i prevenciji egzacerbacije vidjeti dio 5.
neptra
bayer animal health gmbh - флорфеникол, terbinafine hidroklorid, mometasone фуроат - otologicals, kortikosteroidi i противоинфекционные u kombinaciji - psi - za liječenje akutnih pas отита ili akutni i pogoršanja рецидивирующих отитов uzrokovane miješanim infekcijama, osjetljivim sojevima bakterija, osjetljivi na флорфениколу (pseudintermedius aureus) i gljivice je osjetljiva na тербинафину (kvasac je vrsta malassezia pachydermatis).
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - lijekovi za opstruktivne plućne bolesti dišnih putova, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - lijekovi za opstruktivne plućne bolesti dišnih putova, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - lijekovi za opstruktivne plućne bolesti dišnih putova, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.